Advantages over standard hCG trigger: Lower risk of ovarian hyperstimulation syndrome (OHSS) Shorter, more physiological LH surge Potentially safer for high-responder patients Clinical trial status: Multiple trials are evaluating kisspeptin as an IVF trigger, with promising results for reducing OHSS risk
2025 Asset Limits Single applicant: $2,000 in countable assets Married couples: If both are applying, $3,000 total If only one is applying, the applicants income must be $2,000
Relevant reading from Meto's clinical team: Peptides for Insulin Resistance: GLP-1, Tesamorelin and Emerging Compounds Peptide Therapy for PCOS GLP-1, BPC-157 and Hormonal Peptides Meto: Insurance-Covered GLP-1 Care With Ongoing Monitoring If monitoring is your criterion and it should be Meto is the only platform in this comparison that meets the full clinical standard while accepting insurance at a typical out-of-pocket cost of $0$50 per visit
Beneficial effects of converting liver transplant recipients from cyclosporine to tacrolimus on blood pressure, serum lipids, and weight
Holst JJ, Madsbad S, Bojsen-Mller KN, et al
Most protocols recommend administration in a fasted state, typically first thing in the morning before breakfast
